| Patent Number |
Title Of Patent |
Date Issued |
| 7041651 |
Cellular uptake of bioactive agents |
May 9, 2006 |
| Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed "small molecules" into the cells of mammalian tissue, such as the epithelial cells of the mucosa. |
| 6794536 |
Method for preparation of disodium pamidronate |
September 21, 2004 |
| The invention provides a method of preparing anhydrous disodium pamidronate or an aqueous disodium pamidronate solution for pharmaceutical use. |
| 6734170 |
Cellular uptake of bioactive agents |
May 11, 2004 |
| Provided is a composition and a method for increasing cellular uptake of bioactive agents, particularly those compounds termed "small molecules" into the cells of mammalian tissue, such as the epithelial cells of the mucosa. |
| 6268524 |
Method for preparation of disodium pamidronate |
July 31, 2001 |
| The invention provides amorphous disodium pamidronate having no more than about 1-2 wt-% water. |
| 6211169 |
Stable calcitriol solution for packaging into vials |
April 3, 2001 |
| The invention provides a therapeutic calcitriol solution which is suitable for packaging into pharmaceutical vials without producing discoloration of the antioxidant component of the solution. |
| 6160165 |
Method for preparation of disodium pamidronate |
December 12, 2000 |
| The invention includes a method for the preparation of disodium pamidronate comprising: (a) preparing a stirred slurry of pamidronate in water, (b) adding a solution of sodium hydroxide to give a clear solution at pH of about 6.5, (c) filtering the solution and (d) freezing and lyophiliz |
| 4816247 |
Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
March 28, 1989 |
| Lipid emulsion form compositions have been formulated and presented to eliminate adverse injection site reactions associated with the intravenous administration of certain sparingly water soluble, hydrophobic, ionizable drugs in mammals and to provide a solubilized drug form for oral, |
| 4784845 |
Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydr |
November 15, 1988 |
| This disclosure describes quick breaking, in vivo, intravenous, intramuscular, intraarticular fat emulsion compositions which incorporate the use of benzyl alcohol as a consurfactant and/or a cosolvent in combination with materials such as synthetic surfactants, e.g. sorbitan triisos |
| 4575509 |
Water-soluble formulations of m-AMSA with pyroglutamic acid |
March 11, 1986 |
| This invention concerns novel water-soluble salts and compositions of the antitumor agent 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA). More particularly, there are provided (1) the mono- and dipyroglutamate salts of m-AMSA and (2) compositions of m-AMSA with pyroglutamic aci |
| 4416874 |
Injectable compositions of BBM-928A |
November 22, 1983 |
| BBM-928A solutions suitable for parenteral use in animal experiments and having concentrations in the range of 1 mg/ml to 5 mg/ml are described. |
